Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Detalo Health is a deep-tech medical device company based at DTU Science Park in Denmark. Founded in 2018, it focuses on blood volume measurement systems. Its products include Detalo Clinical™ for clinical use and Detalo Performance™ for athletes, research, and training settings. Based on the information on its website, it is closer to a “medical hardware device + PC software” solution than a traditional SaaS platform.
The Detalo blood volume analyzer can measure total blood volume, red blood cell volume, and plasma volume in under 15 minutes. The website states a measurement error of approximately 1.5–2%. The device uses the CO rebreathing method: patients rebreathe through an integrated breathing circuit, supported by external oxygen and carbon monoxide supplies. Disposable antibacterial filters isolate the patient mouthpiece from the breathing circuit, and additional filters can be added for enhanced protection. External PC software automates guidance and control of the measurement steps, and after entering age, height, and weight, it helps determine the CO dose. Under normal use, the website says no special skills are required, and at peak capacity it can complete 3–5 measurements per hour.
The website does not disclose pricing or packages and only provides a “Request a Quote” option. Therefore, procurement costs, maintenance, consumables, and service models need to be confirmed through inquiry. In terms of compliance, Detalo Clinical™ is described as a CE/MDR-certified medical device. The company’s quality management system is ISO 13485 certified, covering design, development, manufacturing, and distribution processes, which is an important endorsement for its use in medical institutions.
Its advantages are fast measurement, clearly stated accuracy information, and no need to inject radioactive materials into patients. The software-guided workflow also reduces the complexity of traditional blood volume assessment. The downside is limited transparency: the site does not disclose information about APIs, cloud deployment, data interfaces, third-party integrations, user permissions, after-sales support, or localization services. The device also depends on external gases, blood sample collection, and blood gas analysis workflows, making implementation more demanding than with pure software products.
It is suitable for hospitals, clinical departments related to intensive care, nephrology, heart failure, and similar fields, research institutions, university laboratories, and high-level sports teams that need to track hemoglobin mass and training outcomes. Access from China cannot be determined from the scraped text. In addition, as a medical device, its clinical use in China may involve local registration, import procedures, and regulatory approvals, but the website does not provide relevant information.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on detalo-health.com official site.
detalo-health.com is an Unknown SaaS provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach detalo-health.com directly.